Sonova Holding AG
SIX:SOON

Watchlist Manager
Sonova Holding AG Logo
Sonova Holding AG
SIX:SOON
Watchlist
Price: 304.5 CHF -0.03% Market Closed
Market Cap: 18.2B CHF
Have any thoughts about
Sonova Holding AG?
Write Note

Sonova Holding AG
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sonova Holding AG
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sonova Holding AG
SIX:SOON
Cash from Financing Activities
-CHf455.9m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
-1%
Metall Zug AG
SIX:METN
Cash from Financing Activities
CHf5.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medacta Group SA
SIX:MOVE
Cash from Financing Activities
-€10.1m
CAGR 3-Years
-19%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Straumann Holding AG
SIX:STMN
Cash from Financing Activities
-CHf424.4m
CAGR 3-Years
N/A
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Medmix Ltd
SIX:MEDX
Cash from Financing Activities
-CHf153.8m
CAGR 3-Years
-53%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Sonova Holding AG
Glance View

Market Cap
18.1B CHF
Industry
Health Care

Sonova Holding AG is a Swiss company that stands at the forefront of the hearing care industry, dedicated to improving the quality of life for individuals with hearing loss. Founded in 1947, Sonova has steadily evolved to become a leader in innovative audiological solutions, encompassing a wide range of hearing aids, cochlear implants, and assistive listening devices. The company operates through well-known brands such as Phonak, Unitron, and Advanced Bionics, catering to a diverse global market. With an unwavering commitment to research and development, Sonova invests significantly in cutting-edge technology and digital solutions, enabling it to set the standard for quality, performance, and sound experience. This innovation not only solidifies its market position but also resonates with its core mission: empowering people to reconnect with their world through better hearing. For investors, Sonova represents a compelling opportunity within a growing industry, driven by demographic trends such as an aging population and increased awareness of hearing health. The company has demonstrated impressive revenue growth and strong profit margins, underpinned by its competitive advantages in R&D and a robust distribution network. In recent years, Sonova has expanded its presence in emerging markets, tapping into new customer bases that present significant long-term growth potential. Additionally, its proactive approach to sustainability and corporate responsibility enhances its appeal, reflecting a commitment to ethical practices and the well-being of the communities it serves. By prioritizing innovation and meeting increasing consumer demand, Sonova is well positioned for continued success, making it an attractive prospect for investors seeking exposure to the healthcare sector.

SOON Intrinsic Value
343.78 CHF
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Sonova Holding AG's Cash from Financing Activities?
Cash from Financing Activities
-455.9m CHF

Based on the financial report for Sep 30, 2024, Sonova Holding AG's Cash from Financing Activities amounts to -455.9m CHF.

What is Sonova Holding AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-1%

Over the last year, the Cash from Financing Activities growth was -23%. The average annual Cash from Financing Activities growth rates for Sonova Holding AG have been 8% over the past three years , 8% over the past five years , and -1% over the past ten years .

Back to Top